In Nav1.7 containing a paroxysmal extreme pain disorder mutation (I1461T), multiple properties are altered, including activation, inactivation, closed-state inactivation, and ramp current responses, resulting in increases in numbers of channels available for activation and open probability in these patients [66]. The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.